Atara Biotherapeutics Inc (NAS:ATRA)
$ 10.28 -1.35 (-11.61%) Market Cap: 58.33 Mil Enterprise Value: 83.40 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 40/100

Atara Biotherapeutics Inc at JPMorgan Healthcare Conference Transcript

Jan 11, 2023 / 11:45PM GMT
Release Date Price: $91.5 (+1.10%)
Tessa Thomas Romero
JPMorgan Chase & Co, Research Division - Associate

Welcome, everyone, to the 41st Annual JPMorgan Healthcare Conference. My name is Tess Romero. I'm one of the senior biotech analysts here at JPMorgan. I'm joined by Taylor Hanley and Adhiraj Chauhan from the team. Our next presenting company is Atara. And speaking on behalf of the company, we have CEO, Pascal Touchon.

Before I turn it over to Pascal, I just wanted to highlight that post the formal presentation, we will have a Q&A session. There is an ask a question button in the portal. So for those on the webcast, please submit your questions, and I'm happy to ask them on your behalf. We will also be taking live questions, so bring your questions for the session here. With that, I'm going to turn it over to Pascal. Pascal?

Pascal Touchon
Atara Biotherapeutics, Inc. - President, CEO & Director

Thank you, Tessa, and thank you, JPMorgan team, for inviting us to present today. It's a real pleasure to be with you in this room that is protected from the weather. And I hope

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot